The Top Takeaways from #BIO2014

Last week’s 2014 BIO International Convention was a whirlwind of passionate discussions, big news, and interesting developments in the world of biotechnology. Take a look at some of the most exciting tidbits shared at BIO this year:

  • Strength of Canada’s Life Science Industry: The life sciences industry contributed more than 65,000 jobs and $40 billion to Canada's economy in 2010.
  • The Advantages of TPP: TPP will provide Canada with the opportunity to improve our IP regime which, as speakers from “The Power of TPP” noted, supports the time and investments required to bring new medicines to market.
  • Faster Medicine Development: BDC Venture Capital, Accel-Rx Health Sciences Accelerator, and CDRD Ventures Inc. announced a collaboration to provide critical seed funding to new and emerging Canadian health sciences companies to bridge the gap between transforming basic research into commercially-viable businesses. 
  • Great Interprovincial Partnerships: The Ontario Centres of Excellence and the Ontario Brain Institute partnered with the Quebec Consortium for Drug Discovery on 3 million interprovincial drug discovery innovation programs.
  • Progress through Incremental Advances: A session on the new paradigm in oncology treatment highlighted how continuous innovation has led to methods of cancer treatments that were unimaginable just a few years ago.
  • Patients at the Center: Panelists at a session focused on fueling the orphan drug pipeline explored the crucial role passionate patient advocates and advocacy organizations play in driving the development of new medicines, especially those for rare diseases.

 

What were your top takeaways this year? Share with us in the comments section or on Twitter or Facebook! Until next year’s convention in Philadelphia, we hope you’ll continue to tune in here for news on Canadian and worldwide developments in biotechnology!